Adverum Biotechnologies IncNASDAQ:ADVM
- LAST PRICE7.5300
- TODAY'S CHANGE (%)0.2500 (3.4341%)
- Bid / Lots7.3000/ 10
- Ask / Lots7.7000/ 1
- Open / Previous Close7.4100 / 7.2800
- Day Range
- 52 Week Range
- Volume381,499
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ADVM |
|---|---|---|
| 09:32 ET | 731 | 7.395 |
| 09:41 ET | 100 | 7.44 |
| 09:45 ET | 7679 | 7.45 |
| 09:48 ET | 284 | 7.445 |
| 09:50 ET | 200 | 7.44 |
| 09:52 ET | 278 | 7.4 |
| 09:56 ET | 5275 | 7.24 |
| 09:57 ET | 790 | 7.22 |
| 09:59 ET | 1300 | 7.32 |
| 10:01 ET | 500 | 7.4199 |
| 10:03 ET | 500 | 7.3999 |
| 10:06 ET | 100 | 7.31 |
| 10:14 ET | 640 | 7.3 |
| 10:17 ET | 2189 | 7.35 |
| 10:19 ET | 200 | 7.35 |
| 10:21 ET | 963 | 7.34 |
| 10:24 ET | 6810 | 7.24 |
| 10:26 ET | 34299 | 7.27 |
| 10:30 ET | 300 | 7.28 |
| 10:33 ET | 200 | 7.3 |
| 10:37 ET | 152 | 7.311 |
| 10:42 ET | 100 | 7.32 |
| 10:48 ET | 100 | 7.33 |
| 10:53 ET | 200 | 7.38 |
| 10:55 ET | 1500 | 7.325 |
| 10:57 ET | 900 | 7.35 |
| 11:00 ET | 300 | 7.36 |
| 11:02 ET | 600 | 7.385 |
| 11:06 ET | 100 | 7.39 |
| 11:08 ET | 4664 | 7.36 |
| 11:11 ET | 2300 | 7.43 |
| 11:15 ET | 35915 | 7.49 |
| 11:18 ET | 15133 | 7.34 |
| 11:20 ET | 2638 | 7.345 |
| 11:22 ET | 46369 | 7.48 |
| 11:24 ET | 200 | 7.48 |
| 11:36 ET | 400 | 7.55 |
| 11:44 ET | 200 | 7.53 |
| 11:45 ET | 1700 | 7.5 |
| 11:47 ET | 1960 | 7.45 |
| 11:49 ET | 100 | 7.465 |
| 11:56 ET | 100 | 7.47 |
| 12:03 ET | 860 | 7.52 |
| 12:07 ET | 5324 | 7.4508 |
| 12:09 ET | 1200 | 7.47 |
| 12:14 ET | 100 | 7.49 |
| 12:21 ET | 108 | 7.480188 |
| 12:23 ET | 200 | 7.46 |
| 12:27 ET | 500 | 7.45 |
| 12:41 ET | 100 | 7.46 |
| 12:43 ET | 200 | 7.47 |
| 12:54 ET | 100 | 7.49 |
| 12:56 ET | 947 | 7.485 |
| 12:59 ET | 100 | 7.515 |
| 01:01 ET | 200 | 7.5 |
| 01:03 ET | 853 | 7.4975 |
| 01:06 ET | 400 | 7.5 |
| 01:08 ET | 400 | 7.49 |
| 01:10 ET | 100 | 7.515 |
| 01:14 ET | 200 | 7.52 |
| 01:17 ET | 850 | 7.5283 |
| 01:19 ET | 700 | 7.54 |
| 01:26 ET | 300 | 7.55 |
| 01:28 ET | 600 | 7.57 |
| 01:30 ET | 533 | 7.56 |
| 01:32 ET | 300 | 7.545 |
| 01:33 ET | 100 | 7.54 |
| 01:35 ET | 100 | 7.53 |
| 01:39 ET | 700 | 7.51 |
| 01:42 ET | 400 | 7.53 |
| 01:46 ET | 500 | 7.52 |
| 01:48 ET | 708 | 7.525 |
| 01:50 ET | 600 | 7.5158 |
| 01:51 ET | 300 | 7.53 |
| 01:57 ET | 100 | 7.53 |
| 02:00 ET | 200 | 7.535 |
| 02:08 ET | 100 | 7.52 |
| 02:09 ET | 100 | 7.54 |
| 02:15 ET | 500 | 7.58 |
| 02:18 ET | 100 | 7.56 |
| 02:20 ET | 400 | 7.56 |
| 02:22 ET | 400 | 7.545 |
| 02:24 ET | 100 | 7.55 |
| 02:27 ET | 100 | 7.53 |
| 02:29 ET | 745 | 7.56 |
| 02:33 ET | 109 | 7.555 |
| 02:38 ET | 800 | 7.56 |
| 02:42 ET | 100 | 7.55 |
| 02:44 ET | 1300 | 7.61 |
| 02:47 ET | 688 | 7.615 |
| 02:51 ET | 300 | 7.63 |
| 02:58 ET | 743 | 7.62 |
| 03:00 ET | 700 | 7.64 |
| 03:02 ET | 330 | 7.645 |
| 03:03 ET | 200 | 7.63 |
| 03:07 ET | 500 | 7.65 |
| 03:09 ET | 5791 | 7.63 |
| 03:12 ET | 200 | 7.6649 |
| 03:14 ET | 688 | 7.62 |
| 03:16 ET | 100 | 7.61 |
| 03:18 ET | 22580 | 7.52 |
| 03:20 ET | 1570 | 7.56 |
| 03:23 ET | 1700 | 7.62 |
| 03:25 ET | 200 | 7.66 |
| 03:27 ET | 1059 | 7.645 |
| 03:30 ET | 1100 | 7.61 |
| 03:32 ET | 100 | 7.6 |
| 03:34 ET | 711 | 7.61 |
| 03:36 ET | 1200 | 7.56 |
| 03:38 ET | 400 | 7.57 |
| 03:39 ET | 1398 | 7.55 |
| 03:41 ET | 4652 | 7.55 |
| 03:43 ET | 1402 | 7.55 |
| 03:45 ET | 127 | 7.5401 |
| 03:48 ET | 15691 | 7.5 |
| 03:50 ET | 900 | 7.5 |
| 03:52 ET | 600 | 7.49 |
| 03:54 ET | 400 | 7.49 |
| 03:56 ET | 569 | 7.47 |
| 03:57 ET | 2100 | 7.52 |
| 03:59 ET | 40761 | 7.53 |
Sep 5, 2024
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:30AM ET on Thursday Sep 05, 2024 by Dow Jones
7:30AM ET on Thursday Sep 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Adverum Biotechnologies Inc | 156.6M | -0.9x | --- |
Generation Bio Co | 165.5M | -1.0x | --- |
Inovio Pharmaceuticals Inc | 144.1M | -1.1x | --- |
Ventyx Biosciences Inc | 148.4M | -0.8x | --- |
Century Therapeutics Inc | 131.3M | -0.8x | --- |
Actuate Therapeutics Inc | 145.7M | 0.0x | --- |
Company Information
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration. Its second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to treat patients suffering from blue cone monochromacy (BCM) via a single IVT injection. It also developing an early-stage pipeline of gene therapy programs.
Contact Information
- Headquarters
- 100 Cardinal WayREDWOOD CITY, CA, United States 94063
- Phone
- 650-649-1004
- Fax
- 650-329-8151
Executives
- Independent Chairman of the Board
- Patrick Machado
- President, Chief Executive Officer, Director
- Laurent Fischer
- Chief Financial Officer
- Linda Rubinstein
- Chief Operating Officer
- Kishor Soparkar
- Chief Medical Officer
- Rabia Ozden
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $156.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.01 |
EPS | $-7.99 |
Book Value | $8.23 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
